Search
-
Wilms’ Tumor and Other Kidney Tumors in Children
Learn about clinical trials available at MSK Kids for children with kidney tumors.
… At MSK Kids, your child may be able to take part in a clinical trial, also known as a clinical research study. In a clinical trial, doctors evaluate a new treatment or combination of treatments to see if they are more effective than current treatments. Nearly every pediatric kidney tumor treatment used
-
Find out how we diagnose acoustic neuroma (vestibular schwannoma) with the help of hearing tests and MRI imaging scans.
… It can be challenging to diagnose acoustic neuroma (vestibular schwannoma). This is in part because the signs and symptoms of an acoustic neuroma — such as hearing loss, ringing in the ear, and dizziness — can resemble complications of other diseases. When you come to MSK, your doctor has likely already
-
-
The Prasad Adusumilli Lab
… Job Title Research Study Assistant Current Position Clinical Fellow, Thoracic Surgery, Weill Cornell Medicine, New York, NY Start Year 2017 End Year 2019
-
… Leadership Murray F. Brennan, MD, FACS -- Vice President for International Programs; Benno C. Schmidt Chair in Clinical Oncology Sir Murray F. Brennan Benno C. Schmidt Chair of Clinical Oncology; Chairman Emeritus, Department of Surgery Memorial Sloan Kettering surgeon T. Peter Kingham T. Peter Kingham
-
News
American Thyroid Association guidelines endorse close observation as a treatment option for many small papillary thyroid tumors rather than surgery. MSK endocrinologist Michael Tuttle MD discusses why monitoring such cancers is a viable approach.
… Thursday, August 31, 2017 VIDEO | 02:27 Active Monitoring of Papillary Thyroid Cancer American Thyroid Association guidelines endorse close observation as a treatment option for many small papillary thyroid tumors rather than surgery. MSK endocrinologist Michael Tuttle MD discusses why monitoring such
-
… Education BS, University of Rochester; Cancer Biology Degree BS Mentor The Michael Overholtzer Lab Start Year 2024 Email [email protected]
-
-
-
News
Learn more about a new treatment for biliary tract cancers with high levels of HER2. The drug zanidatamab has been approved by the FDA, thanks to a clinical trial co-led by MSK.
… Thursday, November 21, 2024 On November 20, 2024, the U.S. Food and Drug Administration granted accelerated approval to the drug zanidatamab (Ziihera ® ) to treat advanced and metastatic bile duct cancer (cholangiocarcinoma) and other biliary tract cancers that have high levels of a protein called HER2